Centene (CNC) Revenue — Quarter Ended Sep 30, 2024
Revenue for the quarter rose compared to both the prior quarter and the same period a year earlier. The increase reflects continued growth in the company's top line.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue for the quarter rose compared to both the prior quarter and the same period a year earlier. The increase reflects continued growth in the company's top line.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$36.9B
Revenue reported for this quarter.
Quarter-over-quarter
+2.6%
Change from the immediately preceding quarter.
Year-over-year
+5.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$144.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $35.3B | +5.3% |
| Mar 31, 2024 | $36.3B | +4.0% |
| Jun 30, 2024 | $36B | +3.3% |
| Sep 30, 2024 | $36.9B | +5.5% |
Revenue performance
The reported revenue was higher than the previous quarter, extending the upward trend seen in recent periods.
Quarterly comparison
Compared to the immediately preceding quarter, revenue increased. When measured against the same quarter one year ago, revenue also showed an increase.
What to watch
The company's filing discussed the transition to a new third-party pharmacy benefit manager, which may influence future revenue patterns.